Socket Preservation After Tooth Extraction Using Autogenous Dentin in Comparison With Other Techniques
| Registry | NCT07608289, acronym SPAD |
|---|---|
| Status | Recruiting |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: none, treatment |
| Enrollment | 80 (Estimated) |
| Sponsor | University of Ostrava (Other); collaborators: University Hospital Ostrava, Private dental practice Jalůvka |
| Conditions | Tooth Extraction Site Healing |
| Interventions | Tooth extraction left to heal spontaneously, Tooth extraction plus collagen sponge, Tooth extraction plus tricalcium phosphate, Tooth extraction plus autogenous dentin (Procedure) |
| Dates | start 2025-01-01, primary completion 2027-12-31 (estimated), completion 2028-12-31 (estimated), first posted 2026-05-27, last updated 2026-05-27 |
| Locations | 1 site in Czechia |
Related Papers Related Patents Related Grants Related Experts
All trials for Tooth Extraction Site Healing All trials of Tooth extraction left to heal spontaneously All trials of Tooth extraction plus collagen sponge
Tooth extraction leads to a substantial reduction in alveolar bone volume, with up to 25% loss within the first year and up to 40-60% within three years. This prospective randomized clinical study aims to compare four commonly used methods of alveolar ridge preservation, evaluating their effectiveness in maintaining bone volume for later prosthetic or implant rehabilitation. Alveolar dimensions will be measured using calibrated CBCT imaging pre-extraction and at six months post-extraction.
The study evaluates four different approaches to alveolar ridge preservation after tooth extraction. Eligible patients aged 18-70 years will undergo minimally traumatic extraction. Four treatment modalities will be compared: 1) Spontaneous healing secured with a stitch (control group), 2) Application of collagen sponge (Parasorb Cone, Resorba, Germany) secured with a stitch, 3) Application of a tricalcium phosphate xenograft (Poresorb TCP, Lasak, Czech Republic) covered with a collagen sponge (Parasorb Cone) and secured with a stitch. 4) Application of autogenous dentin, covered with a collagen sponge (Parasorb Cone) and secured with a stitch. Alveolar ridge dimensions will be measured on CBCT before extraction and again after six months. Primary outcomes include the absolute and relative change in ridge width and height at 1 mm, 3 mm, and 5 mm below the highest point of the alveolar bone as per Del Canto-Díaz, 2019. Patient factors (periodontal biotype, soft tissue phenotype, and vestibular thickness of the alveolar bone) will be recorded to allow subgroup analysis.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Spontaneous healing secured with a stitch (control group) | Active comparator | Procedure: Tooth extraction left to heal spontaneously | Wound after the tooth extraction will be secured with a stitch without addition of any augmentation material. |
| Colagen sponge | Experimental | Procedure: Tooth extraction plus collagen sponge | Wound after the tooth extraction will be filled with a collagen sponge (Parasorb Cone, Resorba, Germany) and secured with a stitch. |
| Tricalcium phosphate xenograft | Experimental | Procedure: Tooth extraction plus tricalcium phosphate | Wound after the tooth extraction will be filled with tricalcium phosphate xenograft (Poresorb TCP, Lasak, Czech Republic), covered with a collagen sponge (Parasorb Cone, Resorba, Germany), and secured with a stitch. |
| Autogenous dentin | Experimental | Procedure: Tooth extraction plus autogenous dentin | Wound after the tooth extraction will be filled with grounded autogenous dentin, covered with a collagen sponge (Parasorb Cone, Resorba, Germany), and secured with a stitch. |
Sex: All, ages: 18 Years to 70 Years
Inclusion Criteria: * 18-70 years * no active periodontitis * signed informed consent with participation in the study * need for extraction of teeth other than third molars * patients requesting only standard/reimbursed care Exclusion Criteria: * drug or alcohol abuse * ongoing chemotherapy * ongoing radiotherapy * pregnancy * ongoing treatment of osteoporosis or other biological treatment with MRONJ risk * low compliance * patients asking for premium care
| Facility | City | Country | Status |
|---|---|---|---|
| University Hospital Ostrava | Ostrava | Czechia | Recruiting |